What's new

Human medicines European public assessment report (EPAR): Dazublys, trastuzumab, Status: Opinion

Human medicines European public assessment report (EPAR): Dazublys, trastuzumab, Status: Opinion

Apr 28, 2025 - 09:02
 0
Human medicines European public assessment report (EPAR): Dazublys, trastuzumab, Status: Opinion
Human medicines European public assessment report (EPAR): Dazublys, trastuzumab, Status: Opinion
Read More

Tags:

Previous Article

Germany’s Merck to buy US biotech SpringWorks for $3.9bn

Next Article

New beverage launches: Suja Organic, New Belgium Brewing and more

Related Posts

Human medicines European public assessment report (EPAR): Spikevax (previously COVID-19 Vaccine Moderna), COVID-19 mRNA vaccine, Date of authorisation: 06/01/2021, Revision: 53, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 22, 2025  0

Business process description for referral procedures

Apr 22, 2025  0

Human medicines European public assessment report (EPAR): Emend, aprepitant, Date of authorisation: 11/11/2003, Revision: 32, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 23, 2025  0